Health policy in Europe – Prof. Monika Steffen EUHEALTH

Chitkara Spaak Centre | European Studies
20 May 202228:13

Summary

TLDRCe script aborde les facteurs clés d'un bon système de soins de santé universelle et de qualité, mettant l'accent sur le pouvoir régulateur de l'autorité publique. Il explique comment le gouvernement peut réguler la formation des médecins, fixer les salaires, négocier les tarifs des médicaments, et définir le panier de soins. Le script compare différents types de systèmes de santé en Europe, en mettant en évidence les dépenses par habitant, la couverture des soins et les paiements à la caisse. Il souligne également le rôle de l'Union européenne dans l'amélioration des systèmes de santé et la lutte contre les inégalités en matière de santé.

Takeaways

  • 👨‍⚕️ L'autorité réglementaire du gouvernement est essentielle pour assurer une bonne couverture et une qualité médicale adéquates dans le système de soins de santé.
  • 🧑‍🎓 Le gouvernement peut réguler la formation des étudiants en médecine et spécialiser le nombre de médecins selon les besoins régionaux et spécifiques.
  • 💼 Il peut fixer les salaires des professionnels de la santé et les tarifs pour les médecins privés, influençant ainsi la tarification des services médicaux.
  • 💊 Le gouvernement peut également négocier les prix des produits pharmaceutiques avec l'industrie pharmaceutique, souvent via les assurances maladie.
  • 🛡️ Le 'panier de soins', c'est-à-dire les soins auxquels les assurés ont droit, peut être défini par le gouvernement, affectant la couverture des soins innovants et coûteux.
  • 🏥 En France, les médecins ont une certaine marge de manœuvre pour les tarifs des consultations, mais ils sont globalement régulés par l'État.
  • 🏭 Les soins de santé sont souvent fournis par des fournisseurs publics ou privés non lucratifs, mais une tendance vers la privatisation et la concurrence est observable.
  • 🏛️ Les systèmes de santé varient d'un pays à l'autre en Europe, allant de services de santé nationaux à des assurances maladie sociales et privées.
  • 💸 Les dépenses de santé par habitant et leur financement public ou privé diffèrent considérablement d'un pays à l'autre, reflétant les choix politiques et économiques.
  • 🌍 L'Union européenne joue un rôle important en encourageant les États membres à améliorer leurs systèmes de santé grâce à des comparaisons et des benchmarks.

Q & A

  • Quels sont les facteurs clés pour avoir un bon système de santé avec une couverture universelle et une certaine qualité des médicaments?

    -Les facteurs clés incluent le pouvoir réglementaire de l'autorité publique et du gouvernement qui peut réguler tous les aspects de la santé, fixer le nombre d'étudiants en médecine, spécialiser les médecins dans certaines régions ou disciplines, réguler les salaires des professionnels de la santé, fixer les tarifs pour les médecins privés et négocier les prix des produits pharmaceutiques.

  • Comment le gouvernement peut-il influencer la spécialisation des médecins?

    -Le gouvernement peut réguler la spécialisation des médecins en décidant par exemple qu'ils doivent exercer dans une région donnée en raison d'un manque de médecins ou en exigeant qu'ils travaillent dans les campagnes pendant les premières années après leurs études.

  • Quelle est la différence entre un service de santé national et une assurance maladie sociale?

    -Un service de santé national est géré et financé par l'État, offrant un accès égal aux services de santé à tous. L'assurance maladie sociale est un système où les fonds sont collectés par des caisses autonomes, généralement basées sur des professions ou des branches industrielles, et les membres ont un accès égal aux services de santé au sein de leur caisse.

  • Comment le gouvernement peut-il réguler les prix des produits pharmaceutiques?

    -Le gouvernement peut réguler les prix des médicaments en négociant avec l'industrie pharmaceutique ou en fixant des tarifs maximums pour les médicaments réimbusables par les assurances maladie.

  • Quel est le rôle de l'assurance maladie sociale dans la tarification des services médicaux?

    -L'assurance maladie sociale peut négocier les tarifs avec les médecins et l'industrie pharmaceutique pour les médicaments, car elle est souvent l'entité qui rémunère ces services et produits.

  • Quelle est la notion de 'panier de soins' dans le contexte des systèmes de santé?

    -Le 'panier de soins' fait référence à l'ensemble des soins auxquels les assurés ont droit. Le gouvernement peut déterminer les soins inclus dans ce panier, notamment en fonction de leur efficacité et de leur coût.

  • Comment les systèmes de santé peuvent-ils influencer la couverture des soins pour les populations défavorisées?

    -Les systèmes de santé peuvent garantir la couverture des soins pour les populations défavorisées en définissant des exonérations de cotisations pour les personnes ayant faible revenu ou en utilisant des fonds publics pour couvrir les contributions d'assurance maladie de ces individus.

  • Quels sont les principaux types de systèmes de santé mentionnés dans le script?

    -Les principaux types de systèmes de santé mentionnés sont le service de santé national, l'assurance maladie sociale et l'assurance maladie privée.

  • Quelle est la différence entre les systèmes de santé en Allemagne, en France et en Suède?

    -En Allemagne, la plupart des dépenses de santé sont couvertes par l'assurance maladie sociale. En France, il y a une combinaison d'assurance maladie sociale et d'assurance maladie complémentaire privée. En Suède, le gouvernement couvre la plupart des dépenses de santé via un service de santé national.

  • Comment les pays à faible revenu comme la Bulgarie et la Roumanie gèrent-ils leurs dépenses de santé?

    -Les pays à faible revenu comme la Bulgarie et la Roumanie ont une couverture de santé plus limitée, avec une part importante des dépenses à la charge des patients (paiement à la carte), en raison de ressources financières limitées.

  • Quels sont les défis auxquels les systèmes de santé sont confrontés dans les pays en développement?

    -Les défis incluent la faible couverture des dépenses de santé par les systèmes d'assurance, une dépense par habitant très faible et la nécessité de mettre en place des systèmes de santé efficaces avec des ressources limitées.

Outlines

00:00

💉 Le rôle de la régulation dans les systèmes de santé

Le paragraphe 1 met en évidence l'importance de la régulation par les autorités publiques et le gouvernement dans la qualité et la couverture des systèmes de santé. Il explique comment le gouvernement peut intervenir pour déterminer le nombre d'étudiants en médecine, les spécialisations médicales nécessaires et les régions où les médecins sont manquants. Le gouvernement peut également fixer les salaires des professionnels de la santé, les tarifs pour les médecins privés et les prix des produits pharmaceutiques. En outre, il peut négocier avec l'industrie pharmaceutique pour réduire les coûts des médicaments et définir le 'panier de soins', c'est-à-dire les traitements auxquels les patients ont droit. Le paragraphe souligne que ces régulations dépendent des valeurs sous-jacentes et de l'opinion publique.

05:01

🏥 Les différents types de systèmes de santé et leur financement

Le paragraphe 2 décrit les trois types principaux de systèmes de santé : le service national de santé, l'assurance maladie sociale et l'assurance maladie privée. Chaque type a ses propres principes et valeurs, comme l'accès égal aux services pour tous. Le financement peut provenir du budget public, des contributions d'assurance sociale ou des primes d'assurance privée. Le paragraphe explique également comment les gouvernements peuvent réguler les tarifs et les contributions, et comment ils peuvent aider à payer les contributions pour les personnes les moins fortunées. L'exemple de la France est utilisé pour illustrer comment le système de solidarité fait en sorte que les personnes les plus à l'aise financièrement contribuent à couvrir les soins des plus démunis.

10:02

📊 Dépenses de santé par pays et système de santé

Le paragraphe 3 présente une analyse statistique des dépenses de santé dans différents pays, notamment l'Allemagne, la France, la Suède, la Bulgarie et la Roumanie. Il compare le financement public et privé et les dépenses de poche. Les pays avec des systèmes de sécurité sociale ont généralement une couverture plus large, tandis que les pays avec des systèmes de santé privés ont des dépenses de poche plus élevées. Le paragraphe souligne également les réformes de contrôle des coûts qui ont conduit à l'introduction de paiements de poche même dans les systèmes de santé traditionnellement sans frais supplémentaires.

15:03

🤑 Les conséquences économiques des systèmes de santé

Le paragraphe 4 discute des implications économiques des systèmes de santé, mettant en évidence les différences de dépenses par pays et les sources de financement. Il explique que pour assurer un accès universel et une qualité élevée aux soins, il est nécessaire que beaucoup de personnes paient plus que ce qu'elles utilisent réellement, pour couvrir les coûts pour les personnes qui paient moins. Le paragraphe compare les dépenses moyennes en Europe et dans d'autres pays, soulignant que les systèmes de santé qui dépensent plus en pourcentage du PIB ont tendance à offrir un meilleur accès aux soins.

20:04

🌍 Les systèmes de santé dans le monde et l'impact de l'UE

Le paragraphe 5 compare les systèmes de santé dans différents pays, y compris les États-Unis et l'Inde, et discute de l'impact du système de santé sur les dépenses et la couverture de la population. Il met en évidence le système de santé américain comme étant extrêmement coûteux et inégalitaire, malgré ses dépenses élevées. Le paragraphe mentionne également l'effort de l'Union européenne pour aider les États membres à améliorer leurs systèmes de santé en utilisant des outils de benchmarking pour identifier et partager les meilleures pratiques.

25:05

📈 L'importance de l'évaluation et de l'amélioration continue

Le paragraphe 6 souligne l'importance de l'évaluation continue et de l'amélioration des systèmes de santé. Il explique comment les comparaisons entre les pays peuvent aider à identifier les domaines où des améliorations sont nécessaires et à partager les bonnes pratiques. L'exemple de la France est utilisé pour illustrer comment les données comparatives ont conduit à des améliorations dans la couverture des soins, en particulier pour les traitements des cancers. Le paragraphe met en évidence la nécessité pour les pays de continuer à apprendre et à s'améliorer pour assurer un accès universel et une qualité élevée aux soins de santé.

Mindmap

Keywords

💡Couverture universelle

La couverture universelle fait référence au principe selon lequel tous les individus d'une société ont accès aux soins de santé de base, indépendamment de leur statut socio-économique. Dans le script, l'accent est mis sur l'importance de cette couverture pour garantir un système de santé de qualité. L'exemple donné est celui des systèmes de santé nationaux qui, bien que ne couvrant pas nécessairement l'ensemble des soins, garantissent un accès universel grâce à des régulations publiques.

💡Autorité réglementaire

L'autorité réglementaire est le pouvoir public qui supervise et contrôle les différents aspects du système de santé pour assurer la qualité et l'accès. Dans le script, il est mentionné que le gouvernement peut réguler le nombre d'étudiants en médecine, les spécialisations médicales et même affecter des médecins dans certaines régions où ils sont nécessaires, illustrant ainsi le rôle clé de l'autorité réglementaire dans la gestion du système de santé.

💡Tarifs des médecins

Les tarifs des médecins se réfèrent au coût des consultations et des services médicaux. Le script explique que le gouvernement peut fixer ces tarifs pour les médecins privés, comme en France où le tarif pour une consultation avec un médecin de famille privé est réglementé à 25 euros. Cela montre comment le gouvernement peut influencer les coûts des soins de santé pour les patients.

💡Négociation des prix

La négociation des prix concerne le processus par lequel les gouvernements ou les assurances maladie discutent avec l'industrie pharmaceutique pour déterminer les coûts des médicaments. Dans le script, il est indiqué que les assurances sociales de santé, qui paient une grande partie des médicaments, négocient les prix avec les fabricants pour obtenir des réductions, ce qui est essentiel pour contenir les coûts du système de santé.

💡Cadre des soins

Le cadre des soins désigne l'ensemble des traitements et des services médicaux auxquels les assurés ont droit. Le script mentionne que le gouvernement peut définir ce cadre, décidant ainsi des nouvelles thérapies qui sont couvertes par les assurances et de leur accessibilité pour la population. Cela peut inclure des traitements innovants, comme les thérapies génétiques, et implique des discussions sur la valeur et les coûts de ces traitements.

💡Assurance maladie privée

L'assurance maladie privée fait référence aux plans de couverture santé fournis par des entreprises privées, souvent en complément des systèmes publics de santé. Le script explique que le gouvernement peut réguler ces assurances, définissant les niveaux de primes et les conditions de couverture, comme c'est le cas dans les pays où l'assurance maladie privée a une part importante dans la couverture de la population.

💡Indépendant médical

Un médecin indépendant est un professionnel de la santé qui exerce en dehors des structures hospitalières ou publiques. Le script mentionne que le gouvernement peut réglementer la pratique médicale indépendante, imposant par exemple des périodes de travail dans les régions défavorisées ou des conditions pour ouvrir un cabinet médical, ce qui influence la répartition des professionnels de santé dans le pays.

💡Solidarité

La solidarité est un principe clé dans de nombreux systèmes de santé européens, où les contribuables ou les assurés paient pour soutenir les soins de santé des autres, y compris ceux qui sont plus malades ou moins fortunés. Le script parle de la solidarité comme un élément essentiel de la couverture santé universelle, où les personnes plus à l'aise financièrement contribuent à couvrir les coûts des soins pour les plus démunis.

💡Assurance maladie sociale

L'assurance maladie sociale est un type de système de santé où les contributions sont basées sur les revenus et où l'ensemble de la population est couverte par des assurances collectives. Le script décrit ce système comme étant courant en Europe, avec des exemples de pays comme l'Allemagne et la France, où les assurances maladie sociales jouent un rôle majeur dans le financement des soins de santé.

💡Système de santé national

Un système de santé national est un modèle où le gouvernement fournit directement les services de santé et assume les coûts. Le script mentionne le Royaume-Uni et la Suède comme exemples de pays ayant des systèmes de santé nationaux, où le gouvernement est le principal financeur et fournisseur de soins de santé.

Highlights

The importance of regulatory power in health care systems for universal coverage and quality medicine.

Government's ability to regulate health care including medical education and specialization.

The role of government in addressing doctor shortages in specific regions.

Regulation of doctors' salaries and tariffs for private doctors by the government.

Government's influence on pharmaceutical product pricing through health insurance negotiations.

The concept of a 'care basket' and how governments decide on the scope of care provided.

The impact of public opinion on government's health care policies and regulations.

How governments set levels of contributions and premiums for private health insurances.

The solidarity principle in French health insurance where the well-off support the less fortunate.

The different types of health care systems: national health service, social health insurance, and private health insurance.

The values and principles behind different health care systems and their funding mechanisms.

The rise of private investment in health care provision and its implications.

Comparison of health care spending and its sources in various European countries.

The average health care expenditure in Europe and the role of social health insurance.

The unique challenges and health care spending in poorer European countries like Bulgaria and Romania.

The contrast between European and American health care systems in terms of cost and coverage.

India's low health care spending as compared to other countries and the need for improvement.

The role of the European Union in benchmarking and improving health care systems across member states.

Transcripts

play00:05

so the key factors

play00:07

in all this to have a good health care

play00:09

system with

play00:11

universal coverage and a certain quality

play00:14

of medicine

play00:15

is the regulatory power of the public

play00:17

authority

play00:19

and government can regulate all aspects

play00:21

of health care even if it's not a

play00:23

national health service it can fix the

play00:25

number of medical students

play00:28

including how many doctors should be

play00:31

specialized for heart disease or cancer

play00:33

disease or whatever

play00:34

uh it could decide this is difficult

play00:37

because the medicine doctors don't like

play00:39

it but the government theoretically can

play00:41

do it by law and say well you have to

play00:43

exercise in that or that region because

play00:46

there are doctors lacking in that region

play00:48

or if you want to be a doctor an

play00:50

independent doctor after your studies

play00:52

you have to work the first six or seven

play00:54

years somewhere in the countryside so

play00:56

government can do all this depends on

play00:59

what are the values at the basis and if

play01:02

public opinion will follow

play01:05

it can fix the salaries or honorary of

play01:08

doctors and all the other health

play01:10

professionals already because many of

play01:11

these professionals are in public

play01:13

employment but it can also fix tariffs

play01:16

for private doctors if i see my private

play01:20

family doctor here in france it costs 25

play01:22

euros that's the tariff of the

play01:24

government the doctor can't take

play01:26

more well he he can take more but then

play01:29

he needs to have a special authorization

play01:32

and a special regime and

play01:35

all sorts of special things it's

play01:36

regulated

play01:37

the government can fix the prices for

play01:39

pharmaceutical products

play01:42

uh

play01:43

very often it's

play01:44

health insurance when the social health

play01:47

insurance who will negotiate with

play01:49

doctors on tariffs and with the

play01:51

pharmaceutical industry for medicine

play01:53

prices because they reimburse it these

play01:56

this money

play01:58

it's not the people who pay it

play02:00

so it's insurance but in cases sometimes

play02:03

when you have

play02:05

a regulation a little bit softer the

play02:07

government will try to negotiate every

play02:10

year with the pharmaceutical industry

play02:13

to see

play02:14

if there are products which we may have

play02:17

for less money

play02:20

or if we accept to reimburse very new

play02:23

products with a high price you know very

play02:26

innovative counter treatment for

play02:28

instance

play02:29

um

play02:30

then will you lower prices for this and

play02:32

this and that because you do it for many

play02:35

years and the production should be

play02:37

cheaper so the government comes in to

play02:39

negotiate very often because

play02:41

finally it's public money who pays this

play02:44

so the government can do lots of things

play02:46

it can also fix the care basket it can

play02:49

decide

play02:50

um

play02:52

his have to respect

play02:55

ah with the head's insurances have to

play02:57

respect okay the care basket is the

play03:01

the the care you are normally entitled

play03:04

to

play03:06

if there is innovative care for instance

play03:09

we have not yet so much security about

play03:13

a new

play03:14

genetic

play03:15

treatment or something like this then

play03:18

there's a security question and there's

play03:20

a price question is it worth to pay so

play03:22

much money for this treatment for just a

play03:25

few patients

play03:27

or just to give a few patients some more

play03:30

months to live is it worth it

play03:33

then doctors say yeah it's also for

play03:35

research we will know more

play03:37

and afterwards we benefit more from it

play03:40

because we are collecting you know

play03:42

clinical experiences and so on so

play03:46

in all these discussions the government

play03:48

will be somewhere present

play03:50

it can decide the level of contributions

play03:53

and even the premiums

play03:55

to private health insurances if

play03:58

the private health insurance

play04:00

have the monopoly for covering the total

play04:03

population as it is the case now in the

play04:05

netherlands and in switzerland then the

play04:07

government will come and regulate how

play04:10

much money they can take from these

play04:12

people

play04:13

and it can define the government who are

play04:15

the free beneficiaries who will be

play04:18

health insured without paying any

play04:20

contribution because people are too poor

play04:22

don't have much money

play04:24

so

play04:25

who can go just walk into a hospital or

play04:27

a doctor's office

play04:30

in health insurance systems generally

play04:32

these people need to be affiliated with

play04:34

health insurance and the problem is who

play04:36

is going to pay the contribution

play04:38

sometimes the government will pay it

play04:40

we'll send the money to the health

play04:42

insurance corresponding to these people

play04:44

sometimes it will be

play04:46

francis find a very good answer they

play04:49

take the money

play04:50

for these poor people about 10 percent

play04:52

of the population is freely insured they

play04:55

don't pay any contribution and they have

play04:56

the same care basket than i have

play04:59

or even

play05:00

more in it they get dental care free

play05:03

which i have to pay out of pocket

play05:05

because otherwise i couldn't afford it

play05:07

so

play05:08

um

play05:10

the government

play05:11

started paying the contribution for this

play05:13

for these people and then it started

play05:15

taking the a special tax from the

play05:18

voluntary from the private complementary

play05:21

voluntary health insurance to say well

play05:24

uh you should contribute also to cover

play05:27

these poor people and they accept it say

play05:30

okay we are nice we are also for

play05:31

solidarity

play05:33

um we will pay you when they read about

play05:36

one percent on their business

play05:38

[Music]

play05:40

turnover per year they will give into

play05:42

this common fund to pay

play05:45

to the public health insurance the

play05:47

equivalent of the contributions these

play05:48

poor people don't pay

play05:50

and now ten years later

play05:53

it's about six or seven percent this tax

play05:56

and the total

play05:59

charge

play06:00

for

play06:01

free affiliation of all this about 10 11

play06:05

of the population

play06:07

is paid by the private complementary

play06:09

health insurances

play06:11

so

play06:12

this is a very complicated uh

play06:16

architecture where the french they are

play06:18

very good in making people who have a

play06:20

little bit more

play06:21

pay for all those who have a little bit

play06:23

less they call this solidarity

play06:25

so the health insurance in france for

play06:27

those who don't have who don't have

play06:29

enough money to pay their own

play06:31

contribution

play06:32

it's paid it's under threshold of income

play06:35

and it's paid by the supplementary

play06:37

private health insurance

play06:40

which covers you know the rest of the

play06:42

population every french person has such

play06:44

a insurance

play06:46

okay

play06:48

now the theoretical summary of the major

play06:51

health care system types

play06:53

all the things i said already are

play06:54

summarized here the type of system

play06:57

national health service social health

play06:58

insurance private health insurance the

play07:01

values and principle principles

play07:03

here it is equal access to services by

play07:06

everyone

play07:08

the funding comes from the public budget

play07:11

from the general taxes

play07:13

the provision is mainly by public

play07:16

providers

play07:17

oh sorry

play07:20

public hospitals or public

play07:23

doctors and the governance is state

play07:26

planning and state control very tight so

play07:29

they have control over their budget

play07:31

that's why their health care system

play07:33

costs less but they have waiting lists

play07:36

social health insurance that will be

play07:38

equal the value will be equal access to

play07:41

services among the members of that

play07:43

special fund because they are organized

play07:45

generally by

play07:46

by a profession so as a fund for

play07:48

engineers as a fund for

play07:51

i don't know for trained

play07:52

drivers and pilots and so on

play07:55

and for industry branches and they have

play07:58

to fix up their budget and they can play

play08:00

a little bit on the on the care basket

play08:03

and on the contributions within the

play08:05

limit fixed by the government

play08:08

also the funding is as i said social

play08:10

contracts insurance contribution

play08:12

according to income

play08:14

or to salary

play08:16

the service provision is either by

play08:18

public providers or private providers

play08:21

but mainly in non-for-profit

play08:25

setups

play08:27

that is changing now a little bit

play08:29

uh the municipalities for instance in

play08:32

several countries among them germany

play08:35

sold their little hospitals which their

play08:37

owns and 100 years and they didn't have

play08:39

enough money to modernize them and so on

play08:42

and it was found out that small

play08:44

hospitals are not really so safe so we

play08:46

should have bigger ones so they sold

play08:48

them to private investors

play08:52

who transformed them into something

play08:55

which is for which is a big business for

play08:58

instance they do only one type of

play09:00

operations and then they're very

play09:02

specialized doctors

play09:04

and they contract them with the

play09:07

social health insurance

play09:09

for the price but they get a lot of

play09:12

activity because public hospitals are

play09:15

not built anymore because the money is

play09:16

not there

play09:18

so a lot of private investment is

play09:19

entering now and it's not always not for

play09:22

profit or they transform it into all

play09:24

people's residency which is a big market

play09:27

so there are a little bit things

play09:29

changing

play09:31

uh governance and regulation well as i

play09:33

said collective bargaining of corporist

play09:36

actors the doctors on the one side the

play09:38

health insurance bodies on the other

play09:40

side

play09:41

and growing state regulation

play09:43

private health insurance access

play09:45

according to your ability to pay

play09:47

premiums

play09:49

higher premiums you get a better care

play09:51

basket

play09:52

better better clinics better doctors

play09:55

private insurance premiums are according

play09:58

to the risk

play09:59

the best client would be somebody who's

play10:01

just 20 years old old has never been ill

play10:04

and it doesn't move very much doesn't

play10:05

have risk for accidents that's the best

play10:07

client

play10:09

um

play10:10

private private

play10:12

for-profit providers so everything will

play10:14

be somehow for profit making even if

play10:17

there's government regulation clinics

play10:19

will be private all people's house will

play10:21

be private there will always be sort of

play10:24

you know calculation for profit

play10:26

and there will be a lot of competition

play10:28

between all these private actors

play10:30

competition which the state can limit

play10:33

we

play10:35

talked a lot in our

play10:37

in our science about regulated

play10:39

competition

play10:41

and regulated private privatization that

play10:44

means we privatize certain things but

play10:46

there will be regulation around it

play10:48

or we allow a lot of competition but it

play10:51

will not be just for money-making

play10:54

there will be something like quality

play10:56

and user satisfaction and things like

play10:59

this will come in into the basket

play11:03

now here's uh summing it up you will see

play11:06

the different health types again

play11:08

i put together in a statistic the

play11:11

funding of the current heads expenditure

play11:13

for 2000

play11:15

it must be 2019.

play11:17

i generally took to the year 19 in order

play11:20

to avoid the kovit incidence

play11:23

so we have seen the percentage of gdp of

play11:25

has expanded so we have seen per capita

play11:29

here it's ppp dollars because the

play11:31

statistic comes from the oacd

play11:34

which works with dollars the other one

play11:36

came from europe european commission

play11:39

they work with euros um

play11:42

so this is just a recall on we have seen

play11:44

these things

play11:45

but i put together here three countries

play11:48

because you have it also in your

play11:50

readings germany france and sweden

play11:53

and then the two poorest countries in

play11:56

our statistics bulgaria and romania so

play11:59

you see here the difference

play12:00

between per capita uh

play12:04

spending

play12:06

it's varies between 6500

play12:09

ppp dollars and

play12:12

1900 let's say in bulgaria that's three

play12:16

times more

play12:18

now the interesting thing which we

play12:19

haven't seen yet is where does this

play12:21

money come from

play12:23

um how much is public spending

play12:26

in this current health expenditure

play12:28

current health expenditure uh means all

play12:31

the expenditure of the health care

play12:33

system which is sort of day after day it

play12:36

it does not include investment if you

play12:39

buy and you

play12:40

build a new hospital that's not in it's

play12:42

just the care and and the salaries for

play12:45

the people who work there and the

play12:46

pharmaceutical products and all this

play12:49

so the public spending would be either

play12:51

the social health insurance or

play12:53

government

play12:54

now

play12:56

and here you have the private health

play12:57

insurance

play12:59

a percentage of this current health

play13:01

expenditure which will be paid by

play13:03

private health insurance if there is one

play13:06

and out of pocket what people will pay

play13:08

out of their pocket

play13:10

okay

play13:11

now let's look at these figures in

play13:12

germany

play13:14

78 of the current health expenditure is

play13:17

paid by the social health insurance so

play13:19

this is a proof that this is a social

play13:21

health insurance

play13:23

type because most of the money is

play13:25

covered by these social health

play13:27

insurances the government gives 6.5

play13:31

so the total public coverage in spending

play13:34

terms it's

play13:36

84.6 percent of the current health

play13:39

expenditure so that's quite a lot

play13:41

so private health insurance is is little

play13:45

uh if i have time i will say a few words

play13:48

about it but

play13:49

maybe tomorrow

play13:50

and out of pocket will be an average

play13:53

something like uh 12 to 13

play13:56

of this

play13:57

current expanded show

play14:00

now the 6.5 will be some government

play14:02

subsidies maybe for special programs

play14:05

like looking after children or for

play14:08

special rare illness or

play14:11

for the poor people's coverage

play14:13

contributions they don't pay the

play14:14

government will pay maybe pay it through

play14:16

the health insurance

play14:18

now in france you have more or less the

play14:21

same

play14:22

the same

play14:23

the same

play14:24

profile

play14:26

except

play14:28

you have seven percent which is covered

play14:30

by private health insurance

play14:32

because the french system has never

play14:36

uh been free when it was when the hedge

play14:39

insurance was uh founded she actually

play14:41

won after the second world war it there

play14:44

was a money problem that didn't have

play14:45

enough money and they said well the

play14:47

people should pay 30 percent and 70

play14:50

should be the health insurance of the

play14:52

expenditure

play14:54

and then

play14:55

different levels were established

play14:57

according to all sorts of criteria

play15:00

so reimbursement was never a hundred

play15:02

percent

play15:03

and that's why

play15:05

private complementary health insurance

play15:08

exists they existed before but it's only

play15:11

health insurance there was no other one

play15:13

and they were kept alive with this

play15:14

complimentary part so all the french

play15:17

people have two health insurances

play15:18

including me

play15:20

um

play15:21

a public one

play15:22

major health insurance which pays these

play15:25

78

play15:26

percent of the expenditure

play15:29

and a private health insurance which

play15:30

will pay

play15:32

uh the rest which i don't reimburse

play15:36

and that is about

play15:38

in average seven percent of the current

play15:40

total expenditure but out of pocket will

play15:42

still be nine point three percent so you

play15:45

see france here is very proud that they

play15:47

have the smallest out of pocket in the

play15:50

whole of europe

play15:51

but they never tell you that you have to

play15:53

pay twice the contribution because into

play15:56

this health insurance the private

play15:58

complimentary one you have to pay

play16:00

contribution

play16:02

and mine takes the solidarity principle

play16:05

they take it in percentage of income

play16:07

so that's rather expensive for what they

play16:10

give back so um

play16:12

they don't count family members for

play16:14

instance if i had five children and an

play16:16

ill husband they would all be insured

play16:18

for the same money then i pay for myself

play16:21

so

play16:22

it's according to need

play16:24

um

play16:25

so this is a little bit

play16:27

true we don't have much out of pocket

play16:29

payment but we should consider that we

play16:32

pay much more contribution than other

play16:33

europeans because we pay twice

play16:37

okay sweden you see they don't have any

play16:40

social health insurance the government

play16:41

pays everything because they have a

play16:43

national

play16:45

national health service

play16:47

so the government pays about 85 percent

play16:49

of the

play16:51

current health expenditure

play16:53

and they have very few

play16:55

private health insurances

play16:57

very little it's just one percent of the

play16:59

expenditure and they have about 14 of

play17:02

out of pocket payments today

play17:05

so it grow there were days when there

play17:07

was zero here

play17:09

zero here and in germany there was zero

play17:11

here

play17:12

and the cost control reforms it has care

play17:16

became more expensive

play17:18

led to the introduction of small sums of

play17:21

out-of-pocket payments but if you sum it

play17:24

all up it's about 10

play17:25

in most countries now

play17:28

okay now let's look at the poor

play17:29

countries bulgaria they have a social

play17:32

health insurance system which pays about

play17:34

half of the expenditure government pays

play17:36

something like 10 percent

play17:38

so you see they have about nearly 40

play17:40

percent out of pocket payments which is

play17:42

a lot

play17:43

considering notably that salaries are

play17:46

low

play17:46

in bulgaria

play17:48

romania

play17:50

they have the the lowest percentage of

play17:53

gdp for health care

play17:55

and the lowest per capita

play17:58

uh

play17:59

spending

play18:00

and you see

play18:02

the government makes a bigger effort

play18:04

than in bulgaria

play18:06

they have little private health

play18:08

insurance and people pay about 20 out of

play18:10

their pocket

play18:12

now if you come to the average for the

play18:13

27 countries in europe who are

play18:16

completely differently organized in

play18:18

their health care systems and they have

play18:20

different levels of

play18:22

being rich or poor as a country and as a

play18:24

health care system you have average uh

play18:28

gdp spending will be nearly 10

play18:31

with 3 700 ppp dollars per person

play18:36

every year so that means a family of

play18:39

four will have

play18:41

a health expenditure on average about 12

play18:44

000 ppp dollars but salaries are

play18:47

something like 2 500. so practically

play18:51

half of the year

play18:52

what these people would earn it will be

play18:54

spent for the health expenditure in

play18:56

average

play18:58

and it's other people who will pay this

play19:00

this means universal access

play19:03

so if you want a country with universal

play19:05

access you have to be prepared to pay

play19:07

for it you pay for a lot of other people

play19:11

or you have a bad care system for all

play19:13

the people this was more or less the

play19:16

common

play19:17

situation in communist countries it was

play19:19

not very expensive and it was all free

play19:21

but it was not very good and only

play19:23

special people could go to very good

play19:25

clinics

play19:26

[Music]

play19:28

so we don't want such a system

play19:30

so if you want universal access

play19:33

for everybody

play19:34

quality access and equal treatment

play19:38

you will have to have a lot of people

play19:40

who pay a lot more than they do actually

play19:42

because i will pay for all those who pay

play19:44

less and spend more

play19:47

because they have the children or

play19:48

because they're very ill and so on

play19:50

that's in the logic of a socialized

play19:52

health care system

play19:54

so the average is about half is social

play19:57

health insurance

play19:58

and the third is government spending so

play20:01

the

play20:03

we can conclude here that the

play20:05

bismarcking system with the social

play20:07

health insurance is still the majority

play20:09

in the european union today

play20:12

uh at least in terms of

play20:14

the coverage of the current expenditure

play20:18

they pay more than half

play20:20

and

play20:21

they have about 20

play20:23

in average of out-of-pocket payments

play20:25

because in these eastern countries they

play20:28

are very high because these countries

play20:30

don't have yet a very mature health care

play20:32

system because of the economic basis and

play20:35

maybe also because they just fail to

play20:38

organize it this is what is said partly

play20:40

in the reading you have and i agree with

play20:42

it

play20:43

now if you look at ocde average because

play20:46

that's more countries

play20:48

all sorts of other countries in it

play20:50

it's the percentage of spending is a

play20:52

little bit less than in europe also see

play20:55

already europe spends more

play20:57

of gdp i know sorry i take back what i

play21:01

said first of all i have to say

play21:04

the oscd

play21:06

includes the u.s health care system

play21:08

and that's a very particular system

play21:11

it costs a lot of money and the results

play21:14

are not very good but in the average

play21:16

this will show

play21:18

so the u.s has

play21:20

spent on health care 17 of its total

play21:23

riches

play21:25

of the gdp

play21:26

it's equivalent to 11 000 ppp dollars

play21:30

for each resident in the us every baby

play21:33

and every grandmother counted that's an

play21:35

enormous a lot of money and with all

play21:38

this money they are not able to cover

play21:40

the total population

play21:42

they don't have

play21:44

a

play21:45

complete coverage as we have in europe

play21:48

so this is in my opinion the worst

play21:51

healthcare system you can have extremely

play21:53

expensive

play21:54

and absolutely unequal

play21:57

and you know this is when you make

play22:00

health care is half

play22:02

a business market

play22:04

now the health insurances are private in

play22:07

america

play22:09

and not even president obama got his

play22:12

plan through for universal health care

play22:14

you have still about 12 of the people in

play22:17

america who have no insurance at all

play22:20

or

play22:21

are very underinsured because they have

play22:24

options they can choose i want to be

play22:25

sure just for this and thus for that

play22:27

which you can't do in europe normally

play22:30

so you're insured once for all and you

play22:33

pay once for this and in america you can

play22:36

choose all sorts of things so people

play22:38

they underensure themselves and then

play22:40

they have a big heads drama

play22:42

and they can't pay

play22:44

um

play22:45

i have read several times that

play22:48

personal bankruptcy in america was

play22:50

mainly due to medical

play22:52

bills people have to declare sell their

play22:55

house have to declare bankruptcy totally

play22:58

because they can't pay their medical

play23:00

bill

play23:01

because it's so ex so expensive

play23:04

and they don't have a proper health

play23:05

insurance so nobody goes bankrupt in

play23:07

europe because of medical bills because

play23:09

we have health insurance compulsory we

play23:11

can't choose we have to have it and if

play23:13

we are too poor then we don't pay the

play23:15

contribution until we earn more money

play23:18

and then we start paying contribution

play23:20

but we will be insured we will not pay

play23:22

the hospital at least not completely we

play23:24

will pay maybe this part but poor people

play23:26

don't pay it

play23:28

at least not in germany france and so on

play23:30

for the eastern countries probably they

play23:32

will have to

play23:33

okay now i put india because i found a

play23:36

few statistics of the o

play23:38

ucd

play23:40

which included india and look at the

play23:42

figures

play23:43

3.6

play23:45

of

play23:46

gdp in india is spent on health care

play23:50

that's the lowest figure of all the

play23:52

countries which were in the statistic

play23:54

and that was

play23:55

the 36 ocde countries plus six or seven

play24:00

others so 40 40 or 44 countries india

play24:03

was the least spender

play24:06

and in p in pps dollars it means 257

play24:11

in 2019 before kovit per capita spending

play24:16

on each indian which is really nothing

play24:19

the government puts about 33 percent of

play24:21

this expenditure probably because

play24:25

of all these public health programs you

play24:27

have in india for rural areas and so on

play24:30

and um

play24:31

11

play24:32

is employer

play24:34

private health insurances people who

play24:36

have a good employment they will have a

play24:37

health insurance a proper one like in

play24:39

europe with their employer

play24:41

and

play24:42

the most of the money will be paid out

play24:44

of pocket so you see there's a lot of

play24:47

things to revise in india probably if

play24:50

you see these statistics oscd

play24:53

includes countries like chile

play24:56

all sorts of brazil and all sorts of

play24:58

countries who are not really

play24:59

particularly rich

play25:01

so

play25:02

and india turned out to be with this

play25:04

booming

play25:05

economy to be the least health spender

play25:08

of all i think it's a good idea to run

play25:11

this master bring some new ideas

play25:14

okay

play25:15

the european union has a powerful role

play25:19

to uh tools to bring

play25:22

the member states into

play25:24

upgrading the healthcare system

play25:26

those who are not very good that they

play25:28

learn to be better

play25:30

so um

play25:31

they make bench benchmarking on all

play25:33

sorts of situations

play25:37

let me give some examples

play25:42

we have benchmarkings in europe on

play25:44

survival

play25:45

rates

play25:47

five years after a heart attack or after

play25:50

cancer all the different types of it

play25:52

counts survival rates for all sorts of

play25:54

illnesses

play25:56

and then you can compare countries and

play25:58

say and we had a case from britain

play26:00

britain had survival data about maybe 15

play26:04

years ago

play26:06

for cancer which were similar to

play26:09

below turkey

play26:12

there was none in europe we had so poor

play26:15

results

play26:16

so britain was very much ashamed when

play26:18

these statistics came up

play26:21

we didn't know before it was a european

play26:22

union who organized this benchmarking

play26:25

and in very very quick time it was i

play26:29

think tony blair in those days britain

play26:31

set up proper cancer services and the

play26:34

survival rights went up very quickly

play26:36

because it was so shameful so you have

play26:39

um

play26:40

you don't have a

play26:42

power at the european union to intervene

play26:44

with the national health care systems

play26:47

but they have all sorts of soft power

play26:49

and benchmarking is one of the very

play26:51

important ones

play26:52

so

play26:54

just a little example about the french

play26:56

report i was reading out of per capita

play26:59

spending in france

play27:01

we know we spent much more than european

play27:04

countries on hospital care

play27:06

much more in pharmaceuticals because we

play27:10

have in france some

play27:12

something against generics

play27:14

doctors don't prescribe much generics so

play27:17

we are still at the end of the european

play27:19

list for use of generic medicine

play27:22

and doctors have total prescription

play27:24

freedom they prescribe what they think

play27:26

is good for the patient and they don't

play27:28

care much about the money which is a

play27:30

good thing

play27:31

but there's also uh economically it's a

play27:34

little bit

play27:36

uh a little bit difficult because uh

play27:39

many people have lots of medicine in

play27:41

their bathroom and it's all to be thrown

play27:43

away afterwards because there's too much

play27:45

prescription and we always have complete

play27:48

packages when you need three pills only

play27:50

they give you the package with 40 pills

play27:52

even if it's very expensive because i

play27:54

don't have packages for three bills

play27:56

so they're all these things

play27:58

um

play27:59

and this comes out when you do compare

play28:01

comparing with european countries before

play28:03

if you look only in your country you

play28:05

think this is normal and you can't

play28:06

change it but you see all the other

play28:08

countries do it differently then you can

play28:10

have new ideas

Rate This

5.0 / 5 (0 votes)

相关标签
Santé universelleCouverture médicaleRégulation gouvernementaleFormation médicaleTarifs médicauxPrix des médicamentsAssurance maladieSystèmes de santéCouverture des soinsSolidarité socialeComparaison internationale
您是否需要英文摘要?